GLAM
AGN

Gardner Lewis Asset Management’s Allergan plc AGN Stock Holding History

Gardner Lewis Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-293,525
Closed -$52M – 79
2020
Q1 		$52M Buy
293,525
+94,625
+48% +$17.8M 8.62% 1
2019
Q4 		$38M Buy
198,900
+158,900
+397% +$28.7M 5.18% 6
2019
Q3 		$6.73M Buy
+40,000
New +$6.52M 1.01% 25
2016
Q4 		– Sell
-13,638
Closed -$3.14M – 125
2016
Q3 		$3.14M Buy
13,638
+3,955
+41% +$966K 0.25% 55
2016
Q2 		$2.24M Buy
9,683
+4,017
+71% +$926K 0.24% 68
2016
Q1 		$1.52M Buy
+5,666
New +$1.62M 0.3% 56

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Gardner Lewis Asset Management's AGN Position: Q2 2020 in Review

Gardner Lewis Asset Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 293,525 shares — an estimated $52M sold.

Gardner Lewis Asset Management first reported a position in AGN in Q1 2016 and held it in 6 quarters. The position peaked at $52M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Gardner Lewis Asset Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 293,525 Allergan plc shares in Q2 2020, an estimated $52M.
  • Gardner Lewis Asset Management first reported a position in Allergan plc in Q1 2016 and held it in 6 quarters.
  • Gardner Lewis Asset Management's Allergan plc position peaked at $52M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Gardner Lewis Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.